Form 4: BioLife Solutions CMO Sells Shares for Tax Obligations

BioLife Solutions' Chief Marketing Officer, Todd Berard, sold 353 shares of common stock to cover tax withholding obligations.

Summary

• Todd Berard, Chief Marketing Officer of BioLife Solutions Inc. (BLFS), reported a sale of common stock.
• The transaction involved the disposition of 353 shares of common stock.
• The shares were sold at a price of $20.74 per share.
• Following this transaction, Mr. Berard beneficially owns 165,940 shares of common stock.
• The sale was executed on March 3, 2026, under a Rule 10b5-1(c) trading plan established on February 24, 2022.
• The purpose of the sale was to satisfy tax withholding obligations related to the vesting of restricted stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale is a routine, non-discretionary transaction for tax purposes, not reflecting a change in management's outlook on the company.

Industry Context

StockSavvy.ai notes that insider sales for tax withholding purposes are a common and routine occurrence, particularly when restricted stock units (RSUs) vest. This type of transaction is generally not indicative of management's sentiment towards the company's future prospects, unlike discretionary sales.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine, non-discretionary sale for tax purposes and does not signal a change in company fundamentals or management confidence.
• No direct impact on employees, customers, suppliers, or creditors.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary sale of shares by a Chief Marketing Officer to cover tax obligations associated with restricted stock vesting. Such transactions, executed under a Rule 10b5-1 plan, are common and do not typically indicate a change in the company's fundamental outlook or management's long-term confidence. Therefore, it provides no new information that would warrant a change in investment recommendation; a 'hold' stance is maintained based solely on this filing.

Keywords

BioLife Solutions, BLFS, Todd Berard, Chief Marketing Officer, Insider Trading, Form 4, Stock Sale, Rule 10b5-1, Tax Withholding, Restricted Stock